{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:33:17Z","timestamp":1791221597290,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.msard.2024.105613","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T16:36:32Z","timestamp":1712594192000},"page":"105613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2231-0172","authenticated-orcid":false,"given":"Roham","family":"Hadidchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rezko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia K.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-2827","authenticated-orcid":false,"given":"Tim Q.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105613_bib42","doi-asserted-by":"crossref","first-page":"727060","DOI":"10.3389\/fnins.2021.727060","article-title":"Nervous System-Systemic Crosstalk in SARS-CoV-2\/COVID-19: A Unique Dyshomeostasis Syndrome","volume":"15","author":"Anand","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.msard.2024.105613_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105031","article-title":"Patients with multiple sclerosis: COVID-19 related disease activity and hospitalisations based on a nationwide cohort study","volume":"79","author":"Andersen","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2024.105613_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/diagnostics14060621","article-title":"Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis","volume":"14","author":"Babar","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.msard.2024.105613_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103985","article-title":"The disease course of multiple sclerosis before and during COVID-19 pandemic: a retrospective five-year study","volume":"65","author":"Babtain","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2024.105613_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001001","article-title":"COVID-19 Among Patients With Multiple Sclerosis: a Systematic Review","volume":"8","author":"Barzegar","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105613_bib44","doi-asserted-by":"crossref","first-page":"1258352","DOI":"10.3389\/fneur.2023.1258352","article-title":"Brain MRI findings in severe COVID-19 patients: a meta-analysis","volume":"14","author":"Boparai","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105613_bib0004","doi-asserted-by":"crossref","DOI":"10.1111\/ene.15477","article-title":"Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study","author":"Bsteh","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105613_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103946","article-title":"COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders","volume":"63","author":"Conway","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105613_bib45","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.msard.2024.105613_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/dom.15120","article-title":"Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: comparison with influenza and pre-pandemic data","author":"Dell'Aquila","year":"2023","journal-title":"Diabetes. Obes. Metab."},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08164622.2021.1947745","article-title":"Disorders of vision in multiple sclerosis","volume":"105","author":"Dhanapalaratnam","year":"2022","journal-title":"Clin. Exp. Optom."},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12938-022-01045-z","article-title":"Deep learning of longitudinal chest X-ray and clinical variables predicts duration on ventilator and mortality in COVID-19 patients","volume":"21","author":"Duanmu","year":"2022","journal-title":"Biomed. Eng. Online"},{"issue":"2","key":"10.1016\/j.msard.2024.105613_bib0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/15459683211065442","article-title":"Cerebellar dysfunction in multiple sclerosis: considerations for research and rehabilitation therapy","volume":"36","author":"Edwards","year":"2022","journal-title":"Neurorehabil. Neural Repair."},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib47","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1038\/s41598-024-58430-y","article-title":"Patients with unmet social needs are at higher risks of developing severe long COVID-19 symptoms and neuropsychiatric sequela","volume":"14","author":"Eligulashvili","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0009","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/diagnostics13010119","article-title":"COVID-19 Patients in the COVID-19 recovery and engagement (CORE) clinics in the bronx","volume":"13","author":"Eligulashvili","year":"2022","journal-title":"Diagnostics. (Basel)"},{"issue":"4","key":"10.1016\/j.msard.2024.105613_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004263","article-title":"Long-term outcomes of hospitalized patients with SARS-CoV-2\/COVID-19 with and without neurological involvement: 3-year follow-up assessment","volume":"21","author":"Eligulashvili","year":"2024","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12883-022-02590-9","article-title":"Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study","volume":"22","author":"Etemadifar","year":"2022","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2024.105613_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102915","article-title":"COVID-19 and the risk of relapse in multiple sclerosis patients: a fight with no bystander effect?","volume":"51","author":"Etemadifar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2024.105613_bib0012","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ejh.14058","article-title":"Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: a 2.5-year follow-up study","volume":"111","author":"Feit","year":"2023","journal-title":"Eur. J. Haematol."},{"issue":"14","key":"10.1016\/j.msard.2024.105613_bib0013","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1021\/acschemneuro.1c00403","article-title":"COVID-19 as a Trigger of Brain Autoimmunity","volume":"12","author":"Gupta","year":"2021","journal-title":"ACS. Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.msard.2024.105613_bib0014","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3324\/haematol.2021.279222","article-title":"Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - A fifteen hospital observational study in the Bronx, New York","volume":"106","author":"Hoogenboom","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.msard.2024.105613_bib0015","article-title":"Clinical characteristics of the first and second COVID-19 waves in the Bronx, New York: a retrospective cohort study","volume":"3","author":"Hoogenboom","year":"2021","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.msard.2024.105613_bib0016","first-page":"574","article-title":"Observational Health Data Sciences and Informatics (OHDSI): opportunities for Observational Researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud. Health Technol. Inform."},{"issue":"3","key":"10.1016\/j.msard.2024.105613_bib0017","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WCO.0000000000000559","article-title":"MRI in multiple sclerosis: clinical and research update","volume":"31","author":"Inglese","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105613_bib0018","doi-asserted-by":"crossref","first-page":"e1914","DOI":"10.1002\/mpr.1914","article-title":"New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: a retrospective cohort study in a large New York City healthcare network","volume":"31","author":"Iosifescu","year":"2022","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.msard.2024.105613_bib0019","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40265-022-01672-9","article-title":"Ocrelizumab: a Review in Multiple Sclerosis","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.msard.2024.105613_bib0020","series-title":"Clinical Predictors of Acute Cardiac Injury and Normalization of Troponin After Hospital Discharge from COVID-19","author":"Lu","year":"2022"},{"key":"10.1016\/j.msard.2024.105613_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfad020","article-title":"Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI","author":"Lu","year":"2023","journal-title":"Nephrol. Dial. TransPlant"},{"key":"10.1016\/j.msard.2024.105613_bib0022","article-title":"Outcomes of Hospitalized Patients With COVID-19 With Acute Kidney Injury and Acute Cardiac Injury","volume":"8","author":"Lu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.msard.2024.105613_bib0023","doi-asserted-by":"crossref","first-page":"e15277","DOI":"10.1016\/j.heliyon.2023.e15277","article-title":"Characteristics of COVID-19 patients with multiorgan injury across the pandemic in a large academic health system in the Bronx","volume":"9","author":"Lu","year":"2023","journal-title":"New York. Heliyon"},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0024","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1038\/s41598-022-22741-9","article-title":"Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge","volume":"12","author":"Lu","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s15010-021-01646-1","article-title":"Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study","volume":"50","author":"Lu","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.msard.2024.105613_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104487","article-title":"Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza","volume":"90","author":"Lu","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0027","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2249.2002.01725.x","article-title":"Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects","volume":"127","author":"Martinez-Caceres","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2024.105613_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419892077","article-title":"Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"8","key":"10.1016\/j.msard.2024.105613_bib0029","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1007\/s10072-021-05373-1","article-title":"The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis","volume":"42","author":"Moghadasi","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2024.105613_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2023-332073","article-title":"COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study","author":"Montini","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2024.105613_bib0031","doi-asserted-by":"crossref","first-page":"e13706","DOI":"10.1111\/eci.13706","article-title":"Estimate false-negative RT-PCR rates for SARS-CoV-2. A systematic review and meta-analysis","volume":"52","author":"Pecoraro","year":"2022","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.msard.2024.105613_bib0032","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200089","article-title":"Occurrence and severity of coronavirus disease 2019 are associated with clinical disability worsening in patients with multiple sclerosis","volume":"10","author":"Peeters","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.msard.2024.105613_bib0033","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.medcli.2022.06.020","article-title":"COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: a case-control study","volume":"160","author":"Rahmani","year":"2023","journal-title":"Med. Clin. (Barc)"},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00284-022-03112-z","article-title":"Comprehensive investigations relationship between viral infections and multiple sclerosis pathogenesis","volume":"80","author":"Sedighi","year":"2022","journal-title":"Curr. Microbiol."},{"issue":"6","key":"10.1016\/j.msard.2024.105613_bib49","doi-asserted-by":"crossref","first-page":"473.e471","DOI":"10.1016\/j.crad.2021.02.005","article-title":"Initial chest radiograph scores inform COVID-19 status, intensive care unit admission and need for mechanical ventilation","volume":"76","author":"Shen","year":"2021","journal-title":"Clin. Radiol."},{"issue":"1","key":"10.1016\/j.msard.2024.105613_bib0035","article-title":"COVID-19 severity in multiple sclerosis: Putting Data Into Context. Neurol","volume":"9","author":"Sormani","year":"2022","journal-title":". Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.msard.2024.105613_bib0036","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40263-018-0568-7","article-title":"Ocrelizumab: a review in multiple sclerosis","volume":"32","author":"Syed","year":"2018","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.msard.2024.105613_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104715","article-title":"SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: a propensity score matched case-control study","volume":"74","author":"Vercellino","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2024.105613_bib0038","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2665-9913(21)00157-0","article-title":"Defining COVID-19-associated hyperinflammatory syndrome in specific populations","volume":"3","author":"Webb","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"12","key":"10.1016\/j.msard.2024.105613_bib0039","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"3","key":"10.1016\/j.msard.2024.105613_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-003257","article-title":"Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study","volume":"11","author":"Xu","year":"2023","journal-title":"BMJ Open. Diabetes. Res. Care"},{"issue":"10","key":"10.1016\/j.msard.2024.105613_bib0041","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/HYPERTENSIONAHA.123.21174","article-title":"Incidence of New-Onset Hypertension Post-COVID-19: comparison With Influenza","volume":"80","author":"Zhang","year":"2023","journal-title":"Hypertension"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:22:00Z","timestamp":1715037720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":49,"alternative-id":["S2211034824001925"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105613","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105613"}}